These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15853439)

  • 1. Potential determinants of drug-drug interaction associated dispensing in community pharmacies.
    Becker ML; Kallewaard M; Caspers PW; Schalekamp T; Stricker BH
    Drug Saf; 2005; 28(5):371-8. PubMed ID: 15853439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands.
    Becker ML; Caspers PW; Kallewaard M; Bruinink RJ; Kylstra NB; Heisterkamp S; de Valk V; van der Veen AA; Stricker BH
    Pharm World Sci; 2007 Apr; 29(2):51-7. PubMed ID: 17187223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
    Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
    Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
    BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory tests in the clinical risk management of potential drug-drug interactions: a cross-sectional study using drug-dispensing data from 100 Dutch community pharmacies.
    Geerts AF; De Koning FH; De Smet PA; Van Solinge WW; Egberts TC
    Drug Saf; 2009; 32(12):1189-97. PubMed ID: 19916585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.
    Ko Y; Malone DC; Skrepnek GH; Armstrong EP; Murphy JE; Abarca J; Rehfeld RA; Reel SJ; Woosley RL
    Drug Saf; 2008; 31(6):525-36. PubMed ID: 18484786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of drug-interaction alerts in community pharmacies.
    Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a wireless handheld medication management device in the prevention of drug-drug interactions in a Medicaid population.
    Malone DC; Saverno KR
    J Manag Care Pharm; 2012; 18(1):33-45. PubMed ID: 22235953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacists' response to complaints of gastroesophageal reflux: A simulated patient study in the Northern United Arab Emirates.
    Boura F; Al-Tabakha MM; Hassan N; Darwich M
    PLoS One; 2023; 18(1):e0279922. PubMed ID: 36607970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment tool for pharmacy drug-drug interaction software.
    Warholak TL; Hines LE; Saverno KR; Grizzle AJ; Malone DC
    J Am Pharm Assoc (2003); 2011; 51(3):418-24. PubMed ID: 21555296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential determinants of prescribers' drug-drug interaction knowledge.
    Ko Y; Malone DC; D'Agostino JV; Skrepnek GH; Armstrong EP; Brown M; Woosley RL
    Res Social Adm Pharm; 2008 Dec; 4(4):355-66. PubMed ID: 19064242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies.
    Abarca J; Colon LR; Wang VS; Malone DC; Murphy JE; Armstrong EP
    J Manag Care Pharm; 2006 Jun; 12(5):383-9. PubMed ID: 16792445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Workload in community pharmacies in the UK and its impact on patient safety and pharmacists' well-being: a review of the evidence.
    Hassell K; Seston EM; Schafheutle EI; Wagner A; Eden M
    Health Soc Care Community; 2011 Nov; 19(6):561-75. PubMed ID: 21623986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of a clinical decision support tool to assess the risk of QT drug-drug interactions in community pharmacies.
    Berger FA; van der Sijs H; van Gelder T; van den Bemt PMLA
    Ther Adv Drug Saf; 2021; 12():2042098621996098. PubMed ID: 33708374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.